SEC Form 4 · accession 0001683168-17-001394
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrey Semechkin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
May 22, 2017
Accepted (ET)
May 24, 2017 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2017 | P | 3,200 | $1.64 | A | 1,528,450 | D | |
| Common StockF1 | holding | — | — | — | 53,334 | I | Bu Corporation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Common Stock is owned by X-Master, Inc., a New Hampshire Corporation of which the reporting person is a sole shareholder.